Clinical Trials Logo

Clinical Trial Summary

The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products


Clinical Trial Description

The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products will include 25 subjects who will test three different coenzyme Q10 products. Serum concentration of coenzyme Q10 will be measured. ;


Study Design


NCT number NCT05272228
Study type Interventional
Source University of Primorska
Contact
Status Completed
Phase N/A
Start date March 9, 2022
Completion date July 15, 2022